Robert O’Neil is an operating executive at Avista Capital Partners. Mr. O’Neil was retained by Avista Capital Partners in 2015. Mr. O’Neil has more than 35 years of operational and strategic business leadership experience and a proven track record of building healthcare businesses in the pharmaceutical and consumer sectors. Most recently, he was Worldwide Vice President of Business Development for Johnson & Johnson’s Consumer Group of Companies. Mr. O’Neil held a variety of roles at Johnson & Johnson over a 20-year career with the company. Concurrent with his most recent position, he was a member of the Consumer Group Operating Committee and a Board Member for the Johnson & Johnson Development Corp. Previously, he was Vice President, Business Development, for Johnson & Johnson’s Pharmaceutical Group from 1994 to 2002. From 1991 to 1993, Mr. O’Neil was Senior Vice President, Sales, Marketing, New Product Development, for Ortho McNeil Pharmaceutical (a fully-owned company of Johnson & Johnson). He was also a member of the Ortho McNeil Pharmaceutical Management Board. Prior to that role, Mr. O’Neil held various leadership positions in sales and marketing with the company beginning in 1974.
Mr. O’Neil received a bachelor’s degree from the Stillman School of Business at Seton Hall University and an M.B.A. from the Tobin College of Business at St. John’s University. Mr. O’Neil currently serves as Director of WellSpring Consumer Healthcare, and previously served as Chairman of the Board of Arcadia Consumer Healthcare and as a Director of OptiNose (NASDAQ: OPTN) and Trimb Healthcare.